https://www.prnewswire.com/news-releases/solarea-bio-investigators-receive-national-academy-of-medicine-healthy-longevity-2022-quickfire-challenge-award-301636366.html
Solarea Bio Investigators Receive National Academy of Medicine Healthy Longevity 2022 Quickfire...
/PRNewswire/ -- Solarea Bio, a clinical stage biotech company, has been selected as an awardee of the NAM Healthy Longevity 2022 QuickFire Challenge,...
national academy of medicine
https://www.prnewswire.com/news-releases/solarea-bio-appoints-new-chief-executive-officer-302574843.html
Solarea Bio Appoints New Chief Executive Officer
/PRNewswire/ -- Solarea Bio, a biotechnology company unlocking the plant-based microbiome to deliver science-backed solutions for healthy living, today...
chief executivesolareabioappointsnew
https://www.prnewswire.com/news-releases/solarea-bio-announces-licensing-agreement-with-adm-301403293.html
Solarea Bio Announces Licensing Agreement with ADM
/PRNewswire/ -- Solarea Bio, a biotech company based in Cambridge, MA that is developing microbial-based solutions to aid human health, today announced it...
licensing agreementsolareabioannouncesadm